Merck's antiviral pill approved in Japan

Freitag, 24. Dezember 2021 11:05

Merck & Co. Inc.'s COVID-19 antiviral pill received the green light from an expert committee from the Japanese Ministry of Health, Labour and Welfare on Friday.

The health ministry is also expected to give its final approval later in the day.

Under the deal between Tokyo and Merck, the company will supply the country with 200,000 courses before the end of the year. Japan ordered 1.6 million courses in total.

Relevante Links: Merck & Co. Inc.
Baha Breaking News (BBN) / MS